VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | -9.1% | 3,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $33,000 | -2.9% | 3,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $34,000 | -27.7% | 3,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $47,000 | -7.8% | 3,000 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $51,000 | -21.5% | 3,000 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $65,000 | -13.3% | 3,000 | -40.0% | 0.01% | -28.6% |
Q1 2021 | $75,000 | +13.6% | 5,000 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $66,000 | +37.5% | 5,000 | 0.0% | 0.01% | +16.7% |
Q3 2020 | $48,000 | -15.8% | 5,000 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $57,000 | +9.6% | 5,000 | 0.0% | 0.01% | -12.5% |
Q1 2020 | $52,000 | -36.6% | 5,000 | 0.0% | 0.01% | -11.1% |
Q4 2019 | $82,000 | +24.2% | 5,000 | 0.0% | 0.01% | +28.6% |
Q3 2019 | $66,000 | -28.3% | 5,000 | 0.0% | 0.01% | -36.4% |
Q1 2019 | $92,000 | -29.8% | 5,000 | 0.0% | 0.01% | -35.3% |
Q4 2018 | $131,000 | +13.9% | 5,000 | 0.0% | 0.02% | +30.8% |
Q3 2018 | $115,000 | +21.1% | 5,000 | 0.0% | 0.01% | +18.2% |
Q2 2018 | $95,000 | +13.1% | 5,000 | 0.0% | 0.01% | +10.0% |
Q1 2018 | $84,000 | +10.5% | 5,000 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $76,000 | -15.6% | 5,000 | 0.0% | 0.01% | -18.2% |
Q3 2017 | $90,000 | +9.8% | 5,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $82,000 | +17.1% | 5,000 | 0.0% | 0.01% | +10.0% |
Q1 2017 | $70,000 | -12.5% | 5,000 | 0.0% | 0.01% | -16.7% |
Q4 2016 | $80,000 | -3.6% | 5,000 | 0.0% | 0.01% | -20.0% |
Q3 2016 | $83,000 | +48.2% | 5,000 | 0.0% | 0.02% | +50.0% |
Q2 2016 | $56,000 | +33.3% | 5,000 | 0.0% | 0.01% | +25.0% |
Q1 2016 | $42,000 | -10.6% | 5,000 | 0.0% | 0.01% | -11.1% |
Q4 2015 | $47,000 | -16.1% | 5,000 | 0.0% | 0.01% | -25.0% |
Q3 2015 | $56,000 | -11.1% | 5,000 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $63,000 | +37.0% | 5,000 | 0.0% | 0.01% | +33.3% |
Q1 2015 | $46,000 | -36.1% | 5,000 | 0.0% | 0.01% | -35.7% |
Q4 2014 | $72,000 | +38.5% | 5,000 | 0.0% | 0.01% | +40.0% |
Q3 2014 | $52,000 | -35.8% | 5,000 | 0.0% | 0.01% | -37.5% |
Q2 2014 | $81,000 | 0.0% | 5,000 | 0.0% | 0.02% | -5.9% |
Q1 2014 | $81,000 | – | 5,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |